Yen-Lin Chen Selected Research

Chronic Kidney Failure (Chronic Renal Failure)

10/2019	Atypical posterior reversible encephalopathy syndrome in a noncompliant hemodialysis patient: Case report and literature review.
7/2015	Post-operative renal function following nephrectomy as part of en bloc resection of retroperitoneal sarcoma (RPS).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yen-Lin Chen Research Topics

Disease

38	Neoplasms (Cancer) 04/2022 - 08/2006
18	Sarcoma (Soft Tissue Sarcoma) 09/2021 - 06/2010
11	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2020 - 07/2011
10	Type 2 Diabetes Mellitus (MODY) 06/2022 - 05/2012
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 04/2014
9	Insulin Resistance 01/2021 - 06/2013
7	Neoplasm Metastasis (Metastasis) 10/2020 - 08/2006
7	Osteosarcoma (Osteogenic Sarcoma) 10/2020 - 10/2011
6	Hypertension (High Blood Pressure) 08/2022 - 11/2011
5	Chordoma 04/2022 - 07/2013
4	Inflammation (Inflammations) 01/2021 - 01/2016
4	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 01/2012
4	Ewing Sarcoma (Sarcoma, Ewing) 01/2019 - 11/2009
4	Lung Neoplasms (Lung Cancer) 01/2018 - 10/2017
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 08/2014
3	Breast Neoplasms (Breast Cancer) 01/2020 - 02/2016
3	Hyperglycemia 01/2020 - 10/2017
2	Wounds and Injuries (Trauma) 04/2022 - 01/2018
2	Chondrosarcoma 09/2021 - 08/2014
2	Colorectal Neoplasms (Colorectal Cancer) 04/2021 - 08/2014
2	Glioma (Gliomas) 01/2021 - 07/2019
2	Decompression Sickness (Bends) 12/2020 - 12/2018
2	Prediabetic State (Prediabetes) 03/2020 - 01/2016
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020 - 10/2018
2	Adenocarcinoma 01/2020 - 04/2012
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2019 - 07/2015
2	Leukemia 01/2019 - 01/2018
2	Chronic Disease (Chronic Diseases) 07/2017 - 01/2015
2	Margins of Excision 10/2016 - 08/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2016 - 07/2013
2	Cachexia 01/2016 - 01/2015
2	Body Weight (Weight, Body) 01/2016 - 01/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016 - 01/2015
2	Atrophy 01/2016 - 01/2015
2	Hyperplasia 05/2013 - 08/2006
2	Aggressive Fibromatosis (Desmoid) 01/2013 - 12/2012
1	Lymph Node Tuberculosis (Scrofula) 09/2022
1	Stomach Neoplasms (Stomach Cancer) 06/2022
1	COVID-19 04/2022
1	Thrombocytopenia (Thrombopenia) 04/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Mouth Neoplasms (Oral Cancer) 01/2022
1	Refractive Errors (Refractive Error) 01/2022

Drug/Important Bio-Agent (IBA)

16	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2013
10	Protons (Proton)IBA 04/2022 - 06/2010
9	Proteins (Proteins, Gene)FDA Link 12/2020 - 11/2007
4	CateninsIBA 04/2021 - 01/2013
4	Messenger RNA (mRNA)IBA 10/2020 - 03/2015
4	protein phosphatase 5IBA 12/2018 - 10/2017
4	ErbB Receptors (EGF Receptor)IBA 02/2015 - 04/2014
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 08/2014
3	RNA (Ribonucleic Acid)IBA 12/2020 - 09/2013
3	Biomarkers (Surrogate Marker)IBA 10/2020 - 11/2011
3	Retinaldehyde (Retinal)IBA 01/2020 - 10/2018
3	Triglycerides (Triacylglycerol)IBA 11/2019 - 10/2012
3	Alanine Transaminase (SGPT)IBA 01/2018 - 07/2011
3	AMP-Activated Protein KinasesIBA 01/2018 - 10/2017
3	Uric Acid (Urate)IBA 01/2015 - 10/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2018
2	CytokinesIBA 09/2021 - 01/2021
2	CCAAT-Enhancer-Binding Protein-deltaIBA 01/2021 - 07/2019
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2014
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2018
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
2	Therapeutic UsesIBA 12/2020 - 01/2020
2	MicroRNAs (MicroRNA)IBA 10/2020 - 09/2019
2	Endothelin-1 (Endothelin 1)IBA 01/2020 - 10/2018
2	MucinsIBA 01/2020 - 04/2012
2	Biological ProductsIBA 09/2019 - 07/2013
2	Vasoconstrictor AgentsIBA 01/2019 - 10/2018
2	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2018
2	tissue-factor-pathway inhibitor 2 (PP5)IBA 12/2018 - 10/2017
2	EnzymesIBA 11/2018 - 05/2012
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2017 - 05/2015
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2016 - 08/2014
2	Gemcitabine FDA Link 01/2016 - 01/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015 - 08/2006
2	Insulin (Novolin)FDA Link 01/2015 - 01/2013
2	AndrogensIBA 05/2013 - 07/2012
2	monascuspiloinIBA 07/2012 - 01/2012
1	Angiotensin IIIBA 08/2022
1	AlbuminsIBA 06/2022
1	CreatinineIBA 06/2022
1	Fibronectins (Fibronectin)IBA 06/2022
1	VaccinesIBA 04/2022
1	AntibodiesIBA 04/2022
1	Platelet Factor 4IBA 04/2022
1	ChAdOx1 nCoV-19IBA 04/2022
1	COVID-19 VaccinesIBA 04/2022
1	CurcuminIBA 01/2022
1	(3,5- bis((4- fluorophenyl)methylidene)- 1- ((1- hydroxy- 2,2,5,5- tetramethyl- 2,5- dihydro- 1H- pyrrol- 3- yl)methyl)piperidin- 4- one)IBA 01/2022

Therapy/Procedure

30	Radiotherapy 04/2022 - 06/2010
16	Therapeutics 09/2022 - 08/2006
11	Drug Therapy (Chemotherapy) 10/2020 - 12/2014
5	Neoadjuvant Therapy 01/2020 - 11/2011
4	Proton Therapy 01/2017 - 11/2009
3	Aftercare (After-Treatment) 01/2016 - 11/2009
2	Renal Dialysis (Hemodialysis) 10/2019 - 01/2014
1	Negative-Pressure Wound Therapy 04/2022